Results 11 to 20 of about 4,670,891 (357)

Mitral Multifocal Papillary Fibroelastoma in a Patient with Aggressive Fibromatosis

open access: yesThe Thoracic & Cardiovascular Surgeon Reports, 2021
Mitral valve fibroelastoma is a rare condition that can be associated with high morbidity rates due to thrombus formation and resulting embolic events. Causative treatment for affected patients is mitral valve surgery.
Philipp P. Müller   +3 more
doaj   +1 more source

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.

open access: yesEuropean Heart Journal, 2021
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions ...
P. García-Pavía   +23 more
semanticscholar   +1 more source

CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement

open access: yesJACC: Case Reports, 2023
Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the management of aggressive hematologic malignancies. However, its role in patients with lymphoma and cardiac metastasis or cardiomyopathy remains undefined due to potentially life ...
Choon Ta Ng, MBBS   +12 more
doaj   +1 more source

CAR T cells produced in vivo to treat cardiac injury

open access: yesScience, 2022
Description Making CAR T cells in vivo Cardiac fibrosis is the stiffening and scarring of heart tissue and can be fatal. Rurik et al. designed an immunotherapy strategy to generate transient chimeric antigen receptor (CAR) T cells that can recognize the ...
Joel G. Rurik   +17 more
semanticscholar   +1 more source

Clinical characteristics of primary atrial tumor and their diagnostic value: A retrospective study of 10 years

open access: yesFrontiers in Surgery, 2023
BackgroundPrimary atrial tumors are relatively rare and predominantly benign. However, some atrial tumors may be malignant and are associated with poor outcome.
Qian Wang   +5 more
doaj   +1 more source

Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

open access: yesJAMA cardiology, 2020
Importance Virus infection has been widely described as one of the most common causes of myocarditis. However, less is known about the cardiac involvement as a complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection ...
R. Inciardi   +15 more
semanticscholar   +1 more source

Cardiac Energy Metabolism in Heart Failure

open access: yesCirculation Research, 2021
Alterations in cardiac energy metabolism contribute to the severity of heart failure. However, the energy metabolic changes that occur in heart failure are complex and are dependent not only on the severity and type of heart failure present but also on ...
G. Lopaschuk   +4 more
semanticscholar   +1 more source

Anaesthetic Management in a Patient of Goldenhar Syndrome Posted for Drainage of Brain Abscess with External Ventricular Drain Insertion [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Goldenhar syndrome or Oculo-auricular Vertebral Dysplasia (OAVD) is characterised by a wide range of congenital anomalies including ocular, auricular, facial, cranial, vertebral and cardiac abnormalities.
Shilpa Shankar   +4 more
doaj   +1 more source

'I'm still here, that's probably the best part'. Lives of those living rurally with an implantable cardioverter defibrillator: a qualitative study

open access: yesRural and Remote Health, 2021
Introduction: The use of implantable cardioverter defibrillators (ICDs) is increasing in both New Zealand and Australia. Also, both countries are experiencing an ageing of their rural populations.
Fiona Doolan-Noble   +3 more
doaj   +1 more source

Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial. [PDF]

open access: yes, 2015
BackgroundTiotropium is an anticholinergic bronchodilator for symptom relief and reducing exacerbations with an established safety profile in patients with chronic obstructive pulmonary disease (COPD).
Decramer, Marc   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy